Circulating Tumor Cells in Prostate Cancer

Circulating tumor cells (CTCs) can provide a non-invasive, repeatable snapshot of an individual patient’s tumor. In prostate cancer, CTC enumeration has been extensively studied and validated as a prognostic tool and has received FDA clearance for use in monitoring advanced disease. More recently, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Brian, Rochefort, Holly, Goldkorn, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875960/
https://www.ncbi.nlm.nih.gov/pubmed/24305656
http://dx.doi.org/10.3390/cancers5041676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875960/
https://www.ncbi.nlm.nih.gov/pubmed/24305656
http://dx.doi.org/10.3390/cancers5041676

Ejemplares similares